<DOC>
	<DOCNO>NCT01232023</DOCNO>
	<brief_summary>This study design evaluate pharmacokinetic pharmacodynamic characteristic indobufen healthy subject .</brief_summary>
	<brief_title>Evaluation Pharmacokinetic Pharmacodynamic Characteristics Indobufen , Anticoagulant Agent</brief_title>
	<detailed_description />
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Indobufen</mesh_term>
	<criteria>Adult male age 19 50 year screen . Subjects body weight ≥ 45 kg within ±20 % ideal body weight : Ideal body weight = ( height [ cm ] 100 ) x0.9 . Subjects receive understood completely information regard current study give write informed consent voluntarily participate study follow instruction specify protocol . Subjects drunken habitually ( exceed 21 units/week , 1 unit = 10 g pure alcohol ) unable abstain drinking study period 2 day prior first administration investigational product study . Subjects deem ineligible investigator base reason , include abnormal laboratory value disease .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Indobufen</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>